| 摘要 |
Disclosed is the hydrochloride salt of formula (I) Further disclosed are: crystalline forms of this salt which show X-ray powder diffraction patterns having characteristic peaks at a diffraction angle (2theta ± 0.1 degree) of 8.9, 10.2, 12.9, 14.2, 15.6, 18.4 and 20.6 degrees; and of 7.3, 10.1, 12.2, 14.6, 15.9, 16.0, 18.7 and 21.8 degrees;a pharmaceutical composition which comprises, as an active ingredient, a compound of formula (I); and a use of a compound of formula (I) for the manufacture of a medicament for treating pollakiuria or urinary incontinence.
|
